Clinical TrialsCefixime Adds No Benefit to Azithromycin in Large Typhoid Trial, Reinforcin... Cefixime Adds No Benefit to Azithromycin in Large Typhoid Trial, Reinforcin... Read Post »
Clinical TrialsZalfermin Fails to Add Fibrosis Benefit to Semaglutide in Phase 2 MASH Tria... Zalfermin Fails to Add Fibrosis Benefit to Semaglutide in Phase 2 MASH Tria... Read Post »
Clinical TrialsMepolizumab Improves Disease Control and Moves Patients Toward Remission in... Mepolizumab Improves Disease Control and Moves Patients Toward Remission in... Read Post »
Clinical TrialsCan Lower-Dose Aspirin Reduce Cancer Risk in People With Lynch Syndrome? Ca... Can Lower-Dose Aspirin Reduce Cancer Risk in People With Lynch Syndrome? Ca... Read Post »
Clinical TrialsPositive Phase 1 Findings Put AC Immune’s Brain-Penetrant NLRP3 Inhib... Positive Phase 1 Findings Put AC Immune’s Brain-Penetrant NLRP3 Inhib... Read Post »
Clinical TrialsLeads Biolabs’ LBL-024 (Opamtistomig) Shows 65% Response Rate in First-Li... Leads Biolabs’ LBL-024 (Opamtistomig) Shows 65% Response Rate in First-Li... Read Post »
Clinical TrialsArcato’s Three-Anesthetic Cocktail Shows Safety and Early Analgesic Activ... Arcato’s Three-Anesthetic Cocktail Shows Safety and Early Analgesic Activ... Read Post »
Clinical TrialsModerna-Merck’s Intismeran Plus KEYTRUDA Shows Positive Phase 3 Resul... Moderna-Merck’s Intismeran Plus KEYTRUDA Shows Positive Phase 3 Resul... Read Post »
Clinical TrialsCould Once-Weekly IcoSema Offer a New Approach to Insulin Treatment in Type... Could Once-Weekly IcoSema Offer a New Approach to Insulin Treatment in Type... Read Post »
Clinical TrialsCan B7-H3-Targeted CAR-T Therapy Open a New Treatment Path for Recurrent Gl... Can B7-H3-Targeted CAR-T Therapy Open a New Treatment Path for Recurrent Gl... Read Post »
Clinical TrialsCan the Chemistry of Exercise Be Delivered in a Daily Pill? Enveda Advances... Can the Chemistry of Exercise Be Delivered in a Daily Pill? Enveda Advances... Read Post »
Clinical TrialsAvexitide Reduces Level 2 and Level 3 Hypoglycemic Events by 55% in Phase 3... Avexitide Reduces Level 2 and Level 3 Hypoglycemic Events by 55% in Phase 3... Read Post »
Clinical TrialsInnoCare Receives China Approval for Phase III Head-to-Head Mesutoclax Tria... InnoCare Receives China Approval for Phase III Head-to-Head Mesutoclax Tria... Read Post »
Clinical TrialsKRYSTAL-10: Adagrasib Plus Cetuximab Does Not Significantly Improve PFS or ... KRYSTAL-10: Adagrasib Plus Cetuximab Does Not Significantly Improve PFS or ... Read Post »
Clinical Trialsargenx Reports Positive Phase 3 ALKIVIA Results for Efgartigimod in Autoimm... argenx Reports Positive Phase 3 ALKIVIA Results for Efgartigimod in Autoimm... Read Post »
Clinical TrialsAstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig in Me... AstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig in Me... Read Post »
Clinical TrialsAstraZeneca and HUTCHMED Report Positive SAFFRON Phase III Results in MET-D... AstraZeneca and HUTCHMED Report Positive SAFFRON Phase III Results in MET-D... Read Post »
Clinical TrialsSecukinumab Nearly Doubles Sustained Remission in Relapsed Polymyalgia Rheu... Secukinumab Nearly Doubles Sustained Remission in Relapsed Polymyalgia Rheu... Read Post »
Clinical TrialsArkBio’s Ziresovir Advances Into FDA-Cleared Phase II Trial in Critically... ArkBio’s Ziresovir Advances Into FDA-Cleared Phase II Trial in Critically... Read Post »
Clinical TrialsClearmind Advances CMND-100 Trial into AUD After Positive Safety Review Clearmind Advances CMND-100 Trial into AUD After Positive Safety Review Read Post »
Clinical TrialsINGREZZA Improves Quality of Life and Daily Functioning in Phase 4 Tardive ... INGREZZA Improves Quality of Life and Daily Functioning in Phase 4 Tardive ... Read Post »
Clinical TrialsLecanemab in the Real World: Duke Study Reveals How Alzheimer’s Therapy P... Lecanemab in the Real World: Duke Study Reveals How Alzheimer’s Therapy P... Read Post »
Clinical TrialsNeOnc Reports 48.9% Six-Month PFS With NEO100 in IDH1-Mutant Glioma NeOnc Reports 48.9% Six-Month PFS With NEO100 in IDH1-Mutant Glioma Read Post »
Clinical TrialsREZILIENT3 Trial Shows PFS Benefit With Zipalertinib Plus Chemotherapy in N... REZILIENT3 Trial Shows PFS Benefit With Zipalertinib Plus Chemotherapy in N... Read Post »
Clinical TrialsLeap’s Sirexatamab Misses PFS Endpoint in mCRC but Shows Greater Benefit ... Leap’s Sirexatamab Misses PFS Endpoint in mCRC but Shows Greater Benefit ... Read Post »
Clinical TrialsBEL512 Shows Positive Phase 2 Results in CRSwNP, Supporting Potential for S... BEL512 Shows Positive Phase 2 Results in CRSwNP, Supporting Potential for S... Read Post »
Clinical TrialsJW Pharmaceutical’s Epaminurad 6 mg Shows Superiority Over Febuxostat... JW Pharmaceutical’s Epaminurad 6 mg Shows Superiority Over Febuxostat... Read Post »
Clinical TrialsShattuck’s SL-325 Advances to Phase 2b in Crohn’s Disease with Durable ... Shattuck’s SL-325 Advances to Phase 2b in Crohn’s Disease with Durable ... Read Post »
Clinical TrialsLZ901 Shows Strong Protection Against Herpes Zoster in Phase III Trial LZ901 Shows Strong Protection Against Herpes Zoster in Phase III Trial Read Post »
Clinical TrialsSilence’s Divesiran Meets Phase 2 Trial Endpoint in Polycythemia Vera Silence’s Divesiran Meets Phase 2 Trial Endpoint in Polycythemia Vera Read Post »
Clinical TrialsSonelokimab Delivers 42.1% ACR50 Response in Phase 3 Psoriatic Arthritis Tr... Sonelokimab Delivers 42.1% ACR50 Response in Phase 3 Psoriatic Arthritis Tr... Read Post »
Clinical TrialsTNX-103 Misses Primary Endpoint, Shows Benefit in More Severe PH-HFpEF TNX-103 Misses Primary Endpoint, Shows Benefit in More Severe PH-HFpEF Read Post »
Clinical TrialsAbCellera’s Phase 2 Data Position ABCL635 as a Potential New Approach to ... AbCellera’s Phase 2 Data Position ABCL635 as a Potential New Approach to ... Read Post »
Clinical TrialsAkeso Advances AK146D1 and Ivonescimab Combination in Breast Cancer Akeso Advances AK146D1 and Ivonescimab Combination in Breast Cancer Read Post »
Clinical TrialsBioMarin Stops BMN 401 Program After ENERGY 3 Trial Misses Key Endpoint BioMarin Stops BMN 401 Program After ENERGY 3 Trial Misses Key Endpoint Read Post »
Clinical TrialsPepGen Advances PGN-EDODM1 in Phase 2 DM1 Trial After DSMB Review PepGen Advances PGN-EDODM1 in Phase 2 DM1 Trial After DSMB Review Read Post »
Clinical TrialsDouble-Shot Fasedienol Nasal Spray Shows Promise in Reducing Social Anxiety Double-Shot Fasedienol Nasal Spray Shows Promise in Reducing Social Anxiety Read Post »
Clinical TrialsPharvaris Study Validates Patient-Reported Outcomes for Rare Acquired Angio... Pharvaris Study Validates Patient-Reported Outcomes for Rare Acquired Angio... Read Post »
Clinical TrialsPacira PCRX-201 Shows Durable 2-Year Benefit in Knee Osteoarthritis Trial Pacira PCRX-201 Shows Durable 2-Year Benefit in Knee Osteoarthritis Trial Read Post »
Clinical TrialsBioVie Reports Positive SUNRISE-PD Trial Results for Bezisterim BioVie Reports Positive SUNRISE-PD Trial Results for Bezisterim Read Post »
Clinical TrialsFridge-Free Tetanus-Diphtheria Vaccine Marks Milestone for Vaccine Science Fridge-Free Tetanus-Diphtheria Vaccine Marks Milestone for Vaccine Science Read Post »
Clinical TrialsClarity Reports Strong Disease Control With 67Cu-SAR-bisPSMA in Phase I/IIa... Clarity Reports Strong Disease Control With 67Cu-SAR-bisPSMA in Phase I/IIa... Read Post »
Clinical TrialsOpti-DOR Trial: Doravirine Matches Dolutegravir While Reducing Weight Gain Opti-DOR Trial: Doravirine Matches Dolutegravir While Reducing Weight Gain Read Post »
Clinical TrialsRisvodetinib Shows Disease-Modifying Biomarker Effects in Phase 2 Parkinson... Risvodetinib Shows Disease-Modifying Biomarker Effects in Phase 2 Parkinson... Read Post »
Clinical TrialsModerna Starts Phase 1 Trial of mRNA-1469 Bundibugyo Ebola Vaccine Moderna Starts Phase 1 Trial of mRNA-1469 Bundibugyo Ebola Vaccine Read Post »
Clinical TrialsCadrenal Refocuses CAD-1005 Strategy Following Competitor’s Phase 3 C... Cadrenal Refocuses CAD-1005 Strategy Following Competitor’s Phase 3 C... Read Post »
Clinical TrialsPhase 3 VISIONARY Trial Shows VOYXACT Stabilizes Kidney Function in IgAN Phase 3 VISIONARY Trial Shows VOYXACT Stabilizes Kidney Function in IgAN Read Post »
Clinical TrialsJAK1/2 Inhibition with Low-Dose Ruxolitinib Reduced Acute GVHD in Haploiden... JAK1/2 Inhibition with Low-Dose Ruxolitinib Reduced Acute GVHD in Haploiden... Read Post »
Clinical TrialsRhythm RM-718 Shows 11.6% BMI Reduction in Hypothalamic Obesity Trial Rhythm RM-718 Shows 11.6% BMI Reduction in Hypothalamic Obesity Trial Read Post »
Clinical TrialsOcular Reports Post Hoc Analysis of Phase 3 SOL-1 Trial Demonstrating Up to... Ocular Reports Post Hoc Analysis of Phase 3 SOL-1 Trial Demonstrating Up to... Read Post »
